Jnba Financial Advisors Pfizer Inc Transaction History

Jnba Financial Advisors

$970 Million
Q4 2024

A detailed history of Jnba Financial Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Jnba Financial Advisors holds 7,915 shares of PFE stock, worth $212,992. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,915

Previous 8,042 1.58%

Holding current value

$212,992

Previous $232,000 9.91%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$24.8 - $30.19 $3,149 - $3,834	-127 Reduced 1.58%	7,915 $209,000
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $95,288 - $107,981	-3,440 Reduced 29.96%	8,042 $232,000
Q2 2024 Jul 22, 2024	SELL	$25.26 - $29.6 $38,849 - $45,524	-1,538 Reduced 11.81%	11,482 $321,000
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $6,860 - $7,878	-265 Reduced 1.99%	13,020 $361,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $1,985 - $2,579	-76 Reduced 0.57%	13,285 $382,000
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $5,134 - $6,001	-160 Reduced 1.18%	13,361 $443,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $16,001 - $18,512	443 Added 3.39%	13,521 $495,000
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $590 - $769	15 Added 0.11%	13,078 $533,000
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $137,107 - $178,978	-3,284 Reduced 20.09%	13,063 $669,000
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $46,910 - $57,266	1,072 Added 7.02%	16,347 $715,000
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $8,840 - $10,482	-190 Reduced 1.23%	15,275 $801,000
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $69,814 - $86,508	-1,526 Reduced 8.98%	15,465 $801,000
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $12,561 - $18,620	304 Added 1.82%	16,991 $1 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $44,025 - $49,873	1,226 Added 7.93%	16,687 $653,000
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $1,908 - $2,152	57 Added 0.37%	15,461 $560,000
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $13,990 - $17,790	418 Added 2.79%	15,404 $567,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $2,571 - $3,017	-81 Reduced 0.54%	14,986 $550,000
Q2 2020 Jul 24, 2020	SELL	$30.12 - $36.54 $3,975 - $4,823	-132 Reduced 0.87%	15,067 $493,000
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $5,108 - $7,299	189 Added 1.26%	15,199 $496,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $24,262 - $27,534	737 Added 5.16%	15,010 $588,000
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $10,559 - $13,692	-325 Reduced 2.23%	14,273 $513,000
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $19,377 - $21,756	524 Added 3.72%	14,598 $632,000
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $200,287 - $220,049	5,341 Added 61.16%	14,074 $598,000
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $4.11 Million - $4.68 Million	-106,724 Reduced 92.44%	8,733 $381,000
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $3.68 Million - $4.46 Million	106,724 Added 1222.08%	115,457 $5.09 Million
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $73,743 - $78,617	2,236 Added 34.42%	8,733 $317,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,497	6,497 $218,000

Others Institutions Holding PFE

# of Institutions

3,224

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Pfizer Inc Transaction History